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A B S T R A C T
Reversal of fatty inﬁltration of pennate rotator cuff muscle after tendon release is hitherto impossible.
The administration of nandrolone starting at the time of tendon release prevents the increase in fat
content, but does not revert established fatty inﬁltration.
We hypothesised that tendon release and myotendinous retraction cause alterations in lipid related
gene expression leading to fatty muscle inﬁltration, which can be suppressed by nandrolone through its
genomic actions if applied immediately after tendon release.
The effects of infraspinatus tendon release and subsequent tendon repair at 16 weeks were studied in
six Swiss Alpine sheep. In the interventional groups, 150 mg nandrolone was administered weekly after
tendon release until sacriﬁce (N22W, n = 6) or starting at the time of repair (N6W, n = 6). Infraspinatus
volume, composition, expressed transcripts, lipids, and selected proteins were analyzed at baseline, 16
and 22 weeks.
Tendon release reduced infraspinatus volume by 22% and increased fat content from 11% to 38%. These
changes were not affected by repair. Fatty inﬁltration was associated with up-regulation of 227 lipid
species, and increased levels of the adipocyte differentiation marker PPARG2 (peroxisome proliferator-
activated receptor gamma 2). Nandrolone abrogated lipid accumulation, halved the loss in ﬁber area
percentage, and up-regulated androgen receptor levels and transcript expression in the N22W but not the
N6W group.
The results document that nandrolone mitigates muscle-to-fat transformation after tendon release via
a general down-regulation of lipid accumulation concomitantly with up-regulated expression of its
nuclear receptor and downstream transcripts in skeletal muscle. Reduced responsiveness of retracted
muscle to nandrolone as observed in the N6W group is reﬂected by a down-regulated transcript response.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.1. Degeneration and repair of the ruptured rotator cuff muscle
Tears of rotator cuff tendons affect a considerable portion of the
elderly population [1,2]. Tendon tears lead to musculotendinous
retraction, which is associated with muscle transformation by a* Corresponding author at: Laboratory for Muscle Plasticity, Department of Orthopedic
E-mail address: mﬂueck@research.balgrist.ch (M. Flück).
1 Equal contribution as ﬁrst author.
http://dx.doi.org/10.1016/j.jsbmb.2016.08.005
0960-0760/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unprogressive increase in fat and connective tissue content at the
expense of contractile material (fatty inﬁltration; [3–5]). Even if
surgical repair is successful, this transformation of muscle
structure is hitherto irreversible (reviewed in [4]) and thereby
interferes with restoration of muscle function. The inﬁltration of
muscle with fat tissue is such a risk factor for the success of tendon
repair, that an increase in fat content close to, or above 50% of totals, University of Zurich, Balgrist Campus, Forchstrasse 340, 8008 Zurich, Switzerland.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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[6]. Muscular changes may render successful reattachment of the
ruptured tendon impossible (reviewed in Ref. [4]), due to
shortening and stiffening of the detached and atrophic muscle.
Thus the prevention of muscular transformation in the retracted
muscle is a high priority to allow successful repair of the
musculotendinous unit after tendon tear.
1.2. Anabolic steroids prevent fat accumulation and increase lean mass
Anabolic steroids are a proposed treatment against the
accumulation of fat and associated muscle atrophy [5] because
they increase lean over fat mass by promoting muscle anabolism
and reducing fat content [7–9]. We recently reported that the
anabolic steroid nandrolone decanoate can prevent the increase in
fat content, but does not mitigate atrophy of rotator cuff muscle in
sheep and rabbit models if administered at the time of tendon
release [10,11]. Anabolic steroids affect a number of systemic and
local aspects of lipid metabolism, which may be implicated in fat
accumulation in tenotomized rotator cuff muscle. Anabolic
steroids reduce lipogenic activity in the liver [12] and enhance
lipolytic activity in adipose tissue [13]. Furthermore, anabolic
steroids inhibit adipocyte differentiation and affect skeletal muscle
directly through genomic effects on transcript expression being
associated with cell growth and proliferation, connective tissue
development and function as shown in rat experiments [13–17].
Tenotomy has been demonstrated to increase phospholipid and
triglyceride content in rat skeletal muscle, which has been
postulated to involve the inﬁltration and expansion of adipogenic
cells, as well as de-differentiation of muscle-associated stem cells
or ﬁbroblast into adipocytes [18–22]. This raises the possibility that
nandrolone prevents fat accumulation in tenotomized muscle
[10,11] by multiple mechanisms in skeletal muscle including the
abrogation of phospholipid and triglyceride synthesis, the
enhancement of lipid oxidation [23,24], through effects on
adipocyte differentiation and/or expression of adipogenic path-
ways in skeletal muscle.
1.3. Ruptured rotator cuff muscle looses responsiveness to nandrolone
Interestingly, nandrolone does not inﬂuence fat accumulation
in rotator cuff muscle in sheep and rabbit models of tendon release
if administered after muscle degeneration has established [10,11].
This biological fact imposes possible limitations for full improve-
ment of muscle function if repair of the tendon is delayed [25,26].
The main cytoplasmic receptor of anabolic steroids, the androgen
receptor [17,27], is abundantly expressed in skeletal muscle. In the
rat androgen receptor expression is sensitive to muscle loading and
also to circulating hormone levels, i.e. being reduced with
unloading and increased with nandrolone [28,29]. This suggests
that the loss in responsiveness of rotator cuff muscle to anabolic
steroids after tendon tear in sheep [30] involves changes in
androgen receptor-mediated gene regulation.
1.4. Aim and hypotheses
The purpose of this study was to investigate 1) whether a muscle-
based molecular mechanism underlies the increased fat content in
sheep infraspinatus muscle 16 weeks after tendon release and 2)
whetherexpression changesexplain its mitigationwhen nandrolone
is administered immediately after tendon release before fatty
inﬁltration is established. As metabolism related targets of nandro-
lone action in skeletal muscle are not established, we ﬁrst carried out
a global assessment of lipid and transcript expression changes with
tendon release and repair. For this purpose, we assessed to which
extent alterations in transcript expression in detached infraspinatusmuscle are suppressed by weekly injections of nandrolone, and
whether the transcript response differs when nandrolone is
administered immediately after tendon release or only after repair,
and whether the response is related to androgen receptor levels. We
speciﬁcally hypothesised that tendon release enhances transcript
expression for gene ontologies (GOs) regulating adipocyte differen-
tiation and lipid metabolism and associated lipid species in detached
infraspinatus muscle, and that nandrolone down-regulates this
expression program.
2. Materials and method
2.1. Experimental design
Eighteen female Swiss Alpine sheep (two years old; provider
Staffelegg, Küttigen (AG), Switzerland) were subjected to release of
the infraspinatus tendon in three interventional groups of six
animals each (CONTROL: 45.3  1.9 kg, N22W: 47.1 0.8 kg, N6W:
48.4 1.5 kg). N22W received weekly injections of 150 mg
nandrolone decanoate (Deca-Durabolin1) into the gluteus max-
imus muscle in the post-operative phase starting immediately
after tendon release. N6W received weekly intramuscular injec-
tions of 150 mg nandrolone decanoate starting at the time of
tendon repair, i.e. after 16 weeks. At 16 weeks, repair was
performed in all groups by a single stage repair of the tendon to the
greater tuberosity. Prior to tendon release (PRE), 16 weeks after
tendon release (TR) and 6 weeks after repair (END) measurements
were made on the operated muscle to characterize retraction,
volume and fat content of the infraspinatus muscle. The measures
were compared to contralateral control muscle at the end of the
experiment (END-CC). Further, biopsy samples from the infra-
spinatus muscle were collected. Biopsies were subjected to the
characterization of muscle composition and transcript expression.
Absolute values for the volumetric and cellular adjustments of
infraspinatus muscle have in part been reported. They are now
included as percentage change to allow the interpretation of the
new measurements on molecular parameters with tendon release
and repair. The experiment was approved by the local federal
authorities (Veterinary Ofﬁce of the Canton of Zurich, application
number 72/2013).
2.2. Tendon release and reattachment
All procedures were carried out on the right shoulder essentially
as described [4,30]. The tendon was released by osteotomy of the
greater tuberosity (20  10  10 mm) using an oscillating saw. The
tendon stump was grasped via its attached bone chip through 2
ﬁgure-of-8 stitches using Fiberwire USP No. 2 sutures (Arthrex, Inc,
Naples, Florida) that passed within a 1.8-mm drill-hole in the bone
chip. Subsequently, the tendon and bone chip, with the tied sutures,
were wrapped in a silicon tube (Silicone Penrose drain tube, 12 mm
diameter; Fortune Medical Instrument, Taipei, Taiwan) to prevent
reattachment through scar tissue. Sixteen weeks later, rotator cuff
repair was performed. The bone chip was reattached to its original
site, or as near as possible by connecting the remaining sutures to a
3.5-mm self-tapping cortical bone screw (Synthes, Paoli, USA) with a
washer. During the ﬁrst three weeks of the rehabilitation period,
stress to the repaired tendon was eased by reducing full weight
bearing through suspension of the sheep in a loose belt and by
attaching a ball to the claws. After 6 weeks of reattachment, the
animals were sacriﬁced.
2.3. Muscle anatomy
Immediately after each surgical intervention, magnetic reso-
nance imaging (MRI) and computed tomography of both shoulders
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scans were evaluated for bone chip retraction, muscle volume
using a Digital Imaging and Communications in Medicine (DICOM)
viewer (OsiriX v.5.6 32-bit) as described [11].
2.4. Sampling of muscle tissue
Biopsies were harvested during each of the surgical inter-
ventions from the middle portion of the lateral compartment of the
operated infraspinatus muscle. This was achieved via Bergstroem
biopsy needles with a 5-mm diameter (Dixons Surgical Instru-
ments LTD, Wickford, UK) through a 15-cm curved incision 2 cm
caudal to the scapular spine. Biopsy samples were rapidly
dissected free of excessive connective tissue and blood, frozen
in melting isopentane and kept individually in sealed 2-mL
cryotubes (Greiner, Frickenhausen, Germany) at 80 C until use.
At the time point of sacriﬁce, the entire infraspinatus muscle and
its contralateral control, were excised under general anesthesia
and frozen at 80 C.
2.5. Characterization of muscle composition (morphometry)
Immunohistochemical detection and morphometric quantiﬁ-
cation of muscle ﬁbers, lipid droplets and extracellular matrix was
carried out essentially as described using cryosections [11,31]. In
brief, cryosections were prepared at 12-mm thickness perpendic-
ularly to the major axis of muscle ﬁbers within the biopsy.
Sections were stored at 80 C until being processed using the
Goldner trichome method to distinguish contractile from connec-
tive tissue, and Red Oil O staining to detect lipid. The stained
sections were digitally recorded using an IX50 microscope with a
digital camera DP72 (Olympus Schweiz AG) that was operated with
the Cell Sens Dimension software (Version 1.6, Olympus Corpora-
tion). Images were exported as tiff-ﬁle into Adobe Photoshop CC
(Adobe Systems Incorporated) or ImageJ software (http://rsbweb.
nih.gov/ij/). Goldner trichome stained sections were analyzed
using the lasso tool for the area percentage of muscle ﬁbers (red
structures) and connective tissue (green and non-stained struc-
tures). Lipid content was assessed in Red Oil O stained sections
from the red signal using a macro with imageJ software (http://
rsbweb.nih.gov/ij/). Numbers from the different ﬁelds were
summed for the respective cellular structures to calculate the
respective area percentages of muscle ﬁbers, lipid and extracellular
matrix for the entire cross section/biopsy. The percentage of
extracellular matrix was calculated as the difference between the
respective area percentage of connective tissue (as estimated from
the Goldner staining) and lipid (as estimated in the Red Oil O
staining).
2.6. Lipidome analysis
Lipid species were analyzed in infraspinatus muscle samples
using ultrahigh performance liquid chromatography–tandem mass
spectrometry coupled by nano electrospray source ionization
(UPLC–nanoESI–MSMS) based on established protocols [6,32] and
SOPs for lipid analysis of the FGCZ. Three biological replicas from
the excised muscle of the operated side (sample END) and its
contralateral control (sample END-CC) from the CONTROL, N6W
and N22W group 6 weeks after repair were analyzed. In brief, 5 mg
of muscle tissue was cryosectioned, compounds extracted in cold
MetOH: MTBE: H20 = 360: 1200: 348 using a full glass Potter type
homogenisator and 10ul of LysoPC (17:0; Avanti Polar Lipids, Inc.
Sigma) and 13C-Sorbitol (Sigma) was added as internal standards.
The upper (non-polar) phase was recovered after a centrifugation
step (5 min at 1000g, at 4 C), collected and stored at 30 C. All
extraction steps were carried out in dichlormethane-rinsed Duranglassware using MS-Grade compounds (CHROMOSOLV1, Sigma).
Prior to analysis the lipid extracts were dried down under a steam
of nitrogen and reconstituted in 100uL of 10 mM ammonium
acetate in 80% aqueous methanol.
Lipid compounds were separated on nanoAquity UPLC (Waters)
equipped with a C18 reversed phase column (HSS T3 1.7 mm,
0.2 mm x 150 mm, Waters) applying a gradient of 5 uM ammo-
niumacetate in acetonitril–water 40:60 v/v (A) and 5uM ammo-
niumacetate in acetonitrile  isopropanol 10:90 v/v (B) from 95% A
to 2% A. The injection volume was 1 mL and a ﬂow of 3 mL/min was
applied. The UPLC was coupled to a Q ExactiveTM Hybrid
Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher) by a
nanoESI source that was operated in positive polarization mode,
applying a voltage of 1.8 kV. The MS was operated in data
independent acquisition mode (All Ion Fragmentation) with
stepped collision energy setting (CE 30–35–40 V). All samples
were injected twice (technical replicates). Mass spectrometry data
sets were processed with Progenesis QI (Nonlinear Dynamics, A
Waters Company). Compound ions were detected and quantiﬁed
by a multi-step procedure including the retention time (RT)
alignment of observed m/z signals, the construction of a consensus
m/z  RT map, grouping of co-eluting adducts and quantiﬁcation of
detected compounds through all samples. Detected compound
ions were further annotated by database searches based on derived
neutral masses, isotopic patterns and the match of observed
fragmentation spectra and theoretical fragmentation spectra.
Database searches were run with a tolerance of 50 mD and
included LipidMaps (www.lipidmaps.org) and the Human Metab-
olome Data Base (HMDB, www.hmdb.ca). Compounds, which
demonstrated signiﬁcant differences (see paragraph ‘statistics’
below), were allocated its respective Pubchem substance identiﬁer
(SID). Data sets were deposited in MetaboLights (http://www.ebi.
ac.uk/metabolights/about) as study MTBLS322.
2.7. Transcript expression
Total RNA was isolated from three biological replicas for all time
points (PRE, TR, END and END-CC) of the CONTROL, N22W and
N6W group as described [33] and selected samples were subjected
to RNA sequencing using standard protocols. In brief, an
approximate of 15 mm3 of cryosections was pooled and processed
using the RNeasy kit (Qiagen). The volume of the sectioned tissue
was estimated based on the cross-sectional area, as measured with
a ruler for representative sections on slides under a microscope,
the thickness and the number of pooled sections. The quantity and
quality of total RNA were evaluated using Qubit1 RNA BR Assay Kit
(LifeTechnologies, USA) and Agilent RNA 6000 Nano kit with the
Agilent 2100 Bioanalyzer instrument (Agilent Technologies Inc.,
Santa Clara, USA), respectively. RNA sample was accepted for the
study when the RIN was 7.0.
Library products were generated from 1 mg total RNA subse-
quent to the removal of ribosomal RNA with the Epicentre Ribo-
ZeroTM Magnetic Gold Kit and fragmentation of the enriched RNA
using the Illumina TruSeq1 Stranded total RNA protocol. Subse-
quently ﬁrst strand cDNA synthesis was carried out using random
hexamers, followed by removal of the RNA template and second
strand cDNA synthesis in the presence of dUTP in place of dTTP.
Next, the 30 ends of the blunt fragments were adenylated, multiple
indexing adapters ligated, the cDNA ampliﬁed using PCR and the
quantity and quality of generated libraries determined by qPCR
with Illumina adapter speciﬁc primers using the Roche Light-
Cycler1 system (Roche Diagnostics, Basel, Switzerland) and an
Agilent Technologies 2100 Bioanalyzer with a DNA-speciﬁc chip,
respectively. Diluted libraries (10 nM) were pooled, used for cluster
generation according to the manufacturer’s recommendations
using TruSeq SR Cluster Kit v3-cBot-HS reagents and sequenced
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high output mode. On average 5000000000 reads were sequenced
per library. Raw reads were cleaned by removing adapter
sequences and by trimming the ﬁrst three and last four bases.Fig.1. Changes in muscle compartments with tendon release and repair. A–F) Representa
of sheep collected before (A–C) and after tendon release and 6 weeks of repair (D–F) for th
for 6 weeks (N6W; B, E) or 22 weeks (N22W; C, F). Arrows and arrowheads point to respe
respectively. White and black scale bars correspond to 200 and 500 micrometers, respect
percentage of the muscle ﬁbers (G), fat (H) and extracellular matrix (I) compartment of 
repair (END vs. TR). *, p < 0.05 vs. PRE. #, p < 0.05 vs. CONTROL. Repeated-measures ANThe resulting high-quality reads were aligned to the current
genome build (Oar_v3.1.75, Ensembl) using STAR (v2.3.0e) [34].
The resulting mapping rate was 90%. Approximately 55% of the
reads corresponded to mRNA. Counting was performed using thetive images of Red Oil O-stained cross sections of biopsies from infraspinatus muscle
e intervention group without (CONTROL; A, D) and with nandrolone administration
ctive examples of individual adipocytes and groups of Red Oil O-positive adipocytes,
ively. G-I) Bar graphs showing mean + standard error (SE) of the changes in the area
infraspinatus muscle, 16 weeks after tendon release (TR. vs. PRE) and 6 weeks after
OVA with post hoc test of Fisher. N = 6 per group.
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(v2.13 with R 3.0.2). Raw signals were expressed as ‘normalized
signals’, reﬂecting the frequency of the individual gene transcripts.
Subsequently the ‘relative concentration’ of gene transcripts was
estimated based on the product of multiplying the ‘normalized
value’ for each transcript with the measured ‘RNA concentration’
per volume of muscle tissue. Data sets were deposited under series
record GSE80374 in the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ezazgo-
mefzupxyf&acc=GSE80374).
2.8. Characterization of protein expression
Relative concentrations of proteins of interest per total protein
were assessed essentially as described [35]. In brief, 10 mg total
proteins in total homogenate from the different sample points for
either intervention, for one sheep each, were loaded in adjacent
lanes aside a common sheep muscle sample and a prestained
molecular weight marker (#161-0374, Biorad) on one 7.5% SDS-
PAGE using precast gels (Biorad Mini-protean TGX Stain-free).
Proteins were separated, western blotted on nitrocellulose
membrane (Schleicher & Schuell, GE Healthcare) and proteins of
interest were detected by incubating the membrane with speciﬁc
antibodies in 5%-milk/1% BSA TTBS and enhanced chemo-
luminescence.
PPARG isoforms 1 and 2 were detected using 1: 10000 dilution of
monoclonal mouse antibody (no. LS-C178333 from LS Bio, Lifespan
Biosciences Inc., LabForce AG, Nunnigen, Switzerland) and 1:
200000 dilution of horse-radish peroxidase-conjugated secondary
antibody (goat anti-mouse, #9917 Sigma). Androgen receptor was
detected using a 1:250 dilution of rabbit pAb PG-21 (#06-680,
Merck Millipore, Zug, Switzerland), respectively, and a 1:200000
dilution of horse-radish peroxidase-conjugated secondary anti-
body against rabbit immunoglobulins (#55676, MP Biomedicals,
Basel, Switzerland). The respective signals were recorded using a
PXi System (Syngene, Labgene Scientiﬁc SA, Chatel St Denis,
Switzerland). Recorded signal was quantiﬁed using Quantity one
(Biorad, Cressier, Switzerland) with the rectangular mode. Signal
was scaled relative to the common sample that was present on all
blots and subsequently normalized to the mean of pooled pre-
values for each blot.Fig. 2. Muscle lipidome after tendon release and repair. Cluster of the fold differences 
infraspinatus muscle for the CONTROL, N6W and N22W group after 16 weeks tendon relea
level alterations are given in color-coding (up: red; down: blue) and are ordered according
left.2.9. Statistics
Statistical tests for muscle composition and protein expression
were carried out using SPSS (version 22, IBM corporation). Effects
on the operated muscle side were assessed with a repeated ANOVA
for the factor ‘intervention group’ (CONTROL, N22W, N6W) and the
repeated factor ‘time point’ (PRE, TR, END). Data were also
compared to the results in the END-CC as revealed by a two-
factorial ANOVA for the factors ‘muscle side’ (operated, contralat-
eral) x ‘intervention group’ (CONTROL, N22W, N6W). A post hoc
test for the least signiﬁcant difference was deemed appropriate for
localizing effects. Results were displayed using Prism (Version 5.01,
GraphPad Software, Inc.). Linear relationships were assessed using
Pearson correlations. A p-value < 0.05 was called signiﬁcant.
‘Relative concentrations’ of gene transcripts were assessed
using permutations of T-tests with the Signiﬁcance Analysis of
Microarrays test (SAM) running as an applet in Microsoft Excel
software [36]. Affected gene transcripts were identiﬁed from a
comparison of paired classes at a false discovery rate (FDR) of 2%,
extracted using a manual process in MS-Excel (Microsoft, Kildare,
Ireland) and subsequently analyzed for affected GOs with
MetaCore software (GeneGo, Thompson Reuters) using the
annotation from homologue human genes. GOs were considered
signiﬁcantly enriched if the p-value of enrichment was below the
FDR and if the counts of altered transcripts for the respective GO
pointed signiﬁcantly in one direction based on a p-value < 0.01 for
a binomial distribution (‘Binomdist’ function in MS-Excel).
Subsequently GOs being associated with the muscle, fat and
extracellular compartment were identiﬁed and extracted based on
whether they contained the mesh terms: ‘muscle’, ‘skeletal muscle’
or ‘ﬁber’; ‘lipid’, ‘fat’; ‘extracellular’, ‘matrix’, ‘connective tissue’ or
‘adhesion’. In case of overlap, only the parent GO was retained.
For the assessment of ion abundance, the mass spectrometry
data set was limited to those compounds being detected in all
analyzed samples. The total lipid signal was deﬁned as the
summed abundance of all ions being detected in one given sample.
For each sample, raw signals of each compound were related to the
internal LysoPC (17:0) standard. Changes were assessed based on
permutations of T-tests using SAM [36]. A paired class design was
applied to identify differences between the operated muscle and
its contralateral control. An unpaired class design was applied tofor 703 detected lipid compounds between the contralateral and operated side of
se and 6 weeks of repair. Three biological replicas were assessed per condition. Lipid
 to the correlation of their response in clusters as indicated in the dendrogram to the
Table 2
Nandrolone-dependent non-polar compounds.
Number, median fold changes and the p-value for lipid classes in sheep
infraspinatus muscle 16 weeks after tendon release and 6 weeks after repair
between the N22W and CONTROL group (n = 3 per group). Values were calculated
from differences versus contralateral controls in the respective group.
N22W
lipid class count median change p-value
fatty acyl 117 0.003 6.0E36
glycerolipid 1 0.005 5.0E01
phospholipid 42 0.001 2.3E13
polyketide 25 0.003 3.0E08
prenol lipid 33 0.004 1.2E10
sphingolipid 9 0.001 2.0E03
sterol lipid 16 0.003 1.5E05
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contralateral differences. A false discovery rate of 5% was deemed
signiﬁcant. Output was exported into MS-Excel for table assembly.
For the altered species, the corresponding lipid class was manually
extracted by consulting the Pubchem entry. Lipid classes were
considered signiﬁcantly enriched if the number of altered lipid
species of the respective class pointed in one direction based on a
p-value < 0.01 (Binomdistribution). Affected lipid compounds and
transcripts were subjected to correlation analysis using the
expression correlation network plugging of the cytoscape software
(2.5.0) at a condition of r > |0.99|.
3. Results
3.1. Anatomic alterations
The changes after 16 weeks of tendon release in the CONTROL
group included a myotendinous retraction of 5.8 + 0.5 cm and a 22%
loss of muscle volume. The area percentage of muscle ﬁbers was
reduced by 30% while the area percentage of fat was increased by
281% (Fig. 1), reaching together with the extracellular matrix a
value corresponding to 38% of total area percentage of the muscle.
Muscle alterations with tendon release were not substantially
altered in the 6 weeks after repair.
Compared to CONTROL, nandrolone administration starting
immediately after tendon release (N22W) prevented the increase
in area percentage of fat (23% vs. 277% and 1% vs. 398%,
respectively) and mitigated the reduction in area percentage of
muscle ﬁbers after tendon release (12% vs. 30% and 16% vs. 35%,
respectively), as well as repair (Fig. 1). The area percentage of the
extracellular matrix was increased by 368% after 16 weeks of
tendon release under nandrolone administration and tended to be
different from the not-signiﬁcantly affected values in the CONTROL
group (p = 0.06). The administration of nandrolone for 6 weeks
starting with tendon repair (N6W) did not affect the changes in
muscle volume (23% vs. 31%) and muscle composition (muscle
ﬁber area: 44% vs. 35%; lipid: 1260& vs. 398%, extracellular
matrix: 260% vs. 240%) as seen in the CONTROL group with tendon
release and repair.
3.2. Metabolic alterations
703 lipid species were detected in the infraspinatus muscle
(Fig. 2). The pool sizes of 227 lipid species in the CONTROL group
were increased after tendon release and 6 weeks of repair
compared with the non-operated contralateral control. The
changes concerned the lipid class of fatty acyls, phospholipids,
prenol lipids, polyketides, sterol lipids and sphingolipids but not
glycolipids (Table 1).Table 1
Alterations in lipids after tendon release and repair.
Number of signiﬁcantly affected lipid species in the non-polar fraction (SAM, FDR = 5%), m
class, respectively, in sheep infraspinatus muscle 16 weeks after tendon release and 6 w
N6W group, respectively (n = 3). Values were calculated based on raw signals of each c
CONTROL 
lipid class count median change [min-max] p
fatty acyl 115 978.6 [4.3–68470.8] 2
glycerolipid 1 1367.5 [1367.5–1367.5] 5
phospholipid 38 103.9 [1.0–13427.5] 4
polyketide 25 1050.6 [14.6–2731.1] 3
prenol lipid 32 831.6 [15.4–14215.4] 2
sphingolipid 10 665.3 [3.9–4226.6] 1
sterol lipid 16 452.7 [1.0–30035.9] 2In the N6W group, 185 of the 227 lipid species in the CONTROL
group were increased after tendon release and repair compared
with the contralateral control (Table 1). In the N22W group, the
administration of nandrolone starting immediately after tendon
release mitigated the increase of lipid species in the operated
muscle (Table 2, Fig. 2). In consequence, in this group no lipid
species was increased after tendon release and repair.
3.3. Expression of androgen receptor and the adipocyte differentiation
marker PPARG
Protein levels of isoform 2 (PPARG2) but not isoform 1 (PPARG1)
were increased 16 weeks after tendon release, in all the three
intervention groups (Fig. 3A–C). Neither of the PPARG isoforms was
affected by nandrolone.
Mean protein levels of the androgen receptor were not affected
16 weeks after tendon release in the CONTROL group but increased
5-fold 6 weeks after repair (Fig. 3D/E). Androgen receptor levels
were increased 6-fold after tendon release under nandrolone
administration in the N22W group and remained at an elevated
level after repair. In the N6W group, nandrolone administration
after repair increased androgen receptor levels above the level
alterations seen after 16 weeks of tendon release but this did not
differ to the effects seen in the CONTROL group.
3.4. RNA concentration with tendon release, repair and nandrolone
administration
RNA concentration per muscle volume was not altered 16 weeks
after tendon release, or 6 weeks after repair in the CONTROL group
(Fig. 4). Nandrolone administration starting after tendon release
(in the N22W group) increased RNA concentration by 67% at
tendon repair (Fig. 4) before RNA concentration decreased below
pre-levels 6 weeks after repair. Nandrolone administration startingedian fold changes per lipid class and the p-value for the change over the entire lipid
eeks after repair (END) versus contralateral controls (END-CC) in the CONTROL and
ompound relative to the internal standard LysoPC (17:0).
N6W
-value count median [min-max] p-value
.00E35 93 10.78 [0.1–4516.2] 1.01E28
.00E01 1 26.59 [26.6] 5.00E01
.00E12 31 4.02 [0.1–839.9] 4.66E10
.00E08 19 14.87 [0.6–238.2] 1.91E06
.00E10 21 15.35 [0.1–12743.5] 4.77E07
.00E03 7 33.98 [8.2–1028.3] 7.81E03
.00E05 13 27.46 [0.4–18206.0] 1.22E04
Fig. 3. Protein levels of adipocyte marker PPARG and androgen receptor. A, D) Representative example of immunoblots showing the abundance of PPARG isoforms and
androgen receptor in infraspinatus muscle prior to tendon release (PRE), at repair (TR) PRE) and 6 weeks after repair (END) in the CONTROL, N6W and N22W groups. The
dividing line illustrates how the records from different blots were assembled. B, C, E) Whisker plots visualizing the median, 25% and 75% conﬁdence interval (central line and
borders of box) and minima/maxima (extremes of the lines) of the protein abundance for the PPARG1 and PPARG2 isoforms, and androgen receptor. *P < 0.05, **P < 0.01 or
***P < 0.005 vs. PRE; +P < 0.05 or ++P < 0.01 vs. TR, #P < 0.05 or ##P < 0.01 vs. CONTROL. Repeated-measures ANOVA with post-hoc test of Fisher. N = 6 per group.
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Fig. 4. Ribonucleic acid concentration with tendon release and nandrolone
administration. Line graph visualizing the mean + SE of RNA concentration in
sheep infraspinatus muscle in the CONTROL, N6W and N22W group. *P < 0.05 vs.
PRE; +P < 0.05 vs. TR, #P < 0.05 vs. CONTROL. Repeated-measures ANOVA with
post-hoc test of Fisher. N = 3 per group.
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concentration by 40%.
3.5. Global alterations in transcript expression with tendon release
13821 gene transcripts were expressed in infraspinatus muscle
(the transcriptome). In the CONTROL group, tendon release
affected the muscle transcriptome in a speciﬁc pattern and this
was further modiﬁed with the subsequent repair (Fig. 5A). The
relative concentration of 1397 transcripts was inﬂuenced 16 weeks
after tendon release: 945 transcripts were down-regulated 16
weeks after tendon release, emphasizing an enriched affection of
GOs being associated with muscle, and contrary to our expectation,
fat (Fig. 5B, Table 3, Table S1). 452 transcripts were up-regulated
after tendon release; being enriched for GOs that are associated
with muscle ﬁbers, the extracellular matrix, the vasculature and
nerves. The highest signiﬁcance for enrichment concerned the GO
of ‘extracellular structure organization’ which transcripts were up-
regulated (Table S1 and S2). A few transcripts being associated with
adipocyte differentiation (i.e. ACSM1, ADIPOQ, FABP4, PLIN1,
PPARG2) and two extracellular factors, only, associated with
dedifferentiation of ﬁbroblasts (i.e. FAP, DPP; [37], were increased
16 weeks after tendon release but the corresponding GO was not
signiﬁcantly affected.
Tendon repair produced qualitative alterations in the expres-
sion pattern of transcripts being associated with contraction,
mitochondrial metabolism and protein translation (Fig. 5A). At the
selected threshold of statistical signiﬁcance (FDR of 2%), none of
the measured transcripts changed in concentration 6 weeks after
repair compared to the situation after tendon release.
3.6. Anabolic steroid stimulates transcript expression
Compared to the response in the CONTROL group, the
concentration of 1994 gene transcripts was increased at repair
with nandrolone administration (in the N22W group) starting with
tendon release. The major theme was the up-regulation of GOs
associated with the extracellular matrix and neurogenesis. As well
GOs associated with skeletal muscle and the catabolism and
biosynthesis of lipids were up-regulated (Fig. 5B; Table S3). The
concentration of thirteen transcripts being associated with
adipocyte differentiation was increased at repair with nandrolone
administration during the 16 weeks after tendon release, but this
did not include PPARG2.
Nandrolone administration starting with repair (in the N6W
group) modiﬁed the response of 10756 gene transcripts; 273 being
increased and 10483 being reduced 6 weeks after repair compared
to the response of the CONTROL group. This response of the N6Wgroup differed to the response of the N22W group to nandrolone
administration during the 16 weeks after tendon release (Fig. 6A).
1722 transcripts, which were increased at repair in the N22W
group compared to the CONTROL group, were down-regulated in
the N6W group with nandrolone administration during the 6
weeks of repair (Fig. 5A). 272 transcripts were similarly up-
regulated in both the N6W and N22W group; the majority of which
was associated with neurogenesis (Table S4). All gene ontologies,
which reﬂected the altered gene transcripts, demonstrated altered
responsiveness to nandrolone administration in function of
whether nandrolone was administered during the 16 weeks after
tendon release (N22W group) or only during the 6 weeks after
repair (N6W group; Fig. 6B). This included 37 gene ontologies
being involved in lipid metabolism, muscle contraction, adhesion
and angiogenesis (Table S3).
3.7. Interdependencies
Network analysis of the correlations between fold changes in
gene transcripts and lipid compounds over all three interventions
identiﬁed 3 major entities which described linear relationships
within the class of lipid compounds and gene transcripts, but not
between them (Fig. 7).
4. Discussion
4.1. Synopsis
The prevention of muscle transformation including ﬁber
atrophy, fat accumulation, and matrix increases is a priority for
successful repair of rotator cuff tendons (reviewed in [4,38]). We
recently demonstrated that the early administration of nandrolone
is a possible measure against the accumulation of intramuscular
fat with tendon release of rotator cuff muscle in sheep [11]. The fat
mobilizing effect of nandrolone has been explained by alterations
in the handling of liver-derived high-density lipoprotein choles-
terol [7,39]. To our knowledge, except for altered expression of the
lipoprotein apolipoprotein D, it is not known whether nandrolone
exerts direct effects on lipid metabolism in skeletal muscle [14,40].
In order to resolve the underlying mechanism, we applied a
combination of high-throughput molecular measurements and
morphometric analysis in an established sheep model for tendon
tears of rotator cuff muscle. The results provide ﬁrst evidence that
nandrolone administration reduces the wasting of muscle ﬁbers
(Fig. 1G) and exerts a global inﬂuence on transcript and lipid
expression in the released infraspinatus muscle. The effect of
nandrolone on the transcriptome differed from the alterations
when nandrolone was administered after repair and this was
related to protein levels of the androgen receptor.
4.2. Limitations
A number of factors may be considered when valuing our data.
First, no time point assessed the early adaptations with tendon
release and the injection of the anabolic steroid. Therefore possibly
important ﬁrst molecular adjustments of muscle to tendon release,
which regulate adipogenesis [41], are missed. However the study
of the early responses to tendon release were not an option for the
current investigation as the focus was on testing the effect of
nandrolone administration on lipid accumulation and conﬁrming
the reduced effect of nandrolone administration in retracted
muscle. Importantly, the injections of the steroid were provided
weekly and prevented the elevation of fat content at the earliest
selected time point of measurement, 16 weeks after tendon release
after which lipid content only tended to increase during repair
(p = 0.11; Fig. 1H). Therefore one would expect that transcript
Fig. 5. Proﬁle of muscle transcriptome alterations with tendon release and nandrolone administration. A) Supervised heat map visualizing the concentration of the 1397
altered gene transcripts in infraspinatus muscle of sheep before (PRE), 16 weeks after tendon release at repair (TR) and 6 weeks after repair (END) in the CONTROL group.
Transcript data were log-transformed, mean-centered for genes and subjected to centered cluster analysis for genes and arrays. Three biological replicas were assessed per
condition. Transcript levels are given in color-coding (up: red; down: blue) and are ordered according to the correlation of their response in clusters as indicated in the
dendrogram. Speciﬁc gene ontologies of interest are indicated with arrows and brackets. B) Sketch of the main GOs, reﬂecting muscle processes and compartments, which
were affected 16 weeks after tendon release without (CONTROL) or with nandrolone administration. Number in brackets refers to the counts of affected transcripts
(increased/decreased) for the respective GO. GOs shown in grey font were not signiﬁcantly affected in a speciﬁc direction. The inﬂuence of nandrolone on fold changes with
tendon release is indicated in black boxes and arrows. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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(or proliferation), lipid biosynthesis and lipid storage, would be
speciﬁcally lowered in 16 weeks released muscles with nandrolone
administration. Secondly, metabolic measurements outside the
muscle compartment were not part of our experiment because the
focus of our investigation was put on the contribution of local
mechanisms to fatty inﬁltration and atrophy of rotator cuff muscle
with tendon release and the altered responsiveness to nandrolone.
Nonetheless, we believe that the present novel observations
apprehend the understanding of the nandrolone-induced mitiga-
tion of fatty inﬁltration and atrophy of the released rotator cuffmuscle and the loss of this response when administration starts
after fatty atrophy has been established.
4.3. Overview of alterations across biological layers
The comparison of the changes in muscle composition and
transcript expression 16 weeks after tendon release revealed that
these did correspond for factors being associated with muscle
ﬁbers and the extracellular matrix. For instance the down-
regulation of GOs associated with muscle contraction did coincide
with the reduction in the area percentage of muscle ﬁbers
Table 3
Gene ontologies demonstrating altered responsiveness to nandrolone when administered after tendon release.
Counts, and p-values of the changes with nandrolone administration in the respective group for gene ontologies which transcripts demonstrated signiﬁcant opposite
regulation with nandrolone administration respective to CONTROL during the response to tendon release (N22W) or during the response to repair (N6W).
N22W (TR vs. PRE) vs. CONTROL (TR vs. PRE) N6W (END vs. TR) vs. CONTROL (END vs. TR)
Processes counts entire
GO
trend p-value counts
affected
counts opposite
trend
trend p-value counts
affected
counts opposite
trend
Fat
cellular lipid metabolic process 1163 up 1.90E02 126 0 down 7.20E21 117 11
glycerolipid metabolic process 419 up 1.90E02 51 0 down 5.70E10 49 2
fatty acid metabolic process 412 up 2.40E03 55 0 down 2.90E08 52 5
phospholipid metabolic process 390 up 7.90E03 50 0 down 1.70E08 47 3
positive regulation of lipid metabolic
process
200 up 2.20E05 37 0 down 8.30E05 36 4
glycerophospholipid metabolic process 316 up 1.20E02 41 0 down 3.70E07 39 2
regulation of lipid biosynthetic process 222 up 8.50E06 41 0 down 6.90E04 37 6
glycerolipid biosynthetic process
positive regulation of lipid
268 up 1.10E02 36 0 down 9.20E06 34 2
biosynthetic process 119 up 5.50E05 25 0 down 2.60E03 25 2
phospholipid biosynthetic process 280 up 2.10E02 36 0 down 9.20E06 34 2
glycerophospholipid biosynthetic
process
240 up 1.80E02 32 0 down 1.20E04 30 2
lipid modiﬁcation 185 up 6.00E04 31 0 down 8.40E03 28 4
Skeletal muscle
muscle system process 376 up 4.90E11 75 0 down 5.30E11 68 7
regulation of muscle system process 293 up 6.40E08 56 0 down 5.10E09 52 4
muscle contraction 299 up 5.30E08 57 0 down 2.50E07 51 6
muscle structure development 703 up 6.50E06 99 0 down 1.60E07 82 20
regulation of muscle contraction 223 up 6.40E07 44 0 down 7.70E06 40 4
muscle cell differentiation 421 up 9.40E05 62 0 down 4.20E07 55 8
striated muscle contraction 125 up 5.60E07 30 0 down 4.10E04 28 2
muscle tissue development 454 up 1.20E03 61 0 down 2.90E04 51 12
striated muscle tissue development 431 up 9.20E04 59 0 down 7.60E04 49 12
muscle cell development 218 up 3.10E04 36 0 down 3.20E03 32 5
cardiac muscle tissue development 258 up 2.80E04 41 0 down 6.10E03 35 7
positive regulation of muscle cell
differentiation
134 up 9.20E04 24 0 down 8.90E03 23 2
regulation of striated muscle contraction 124 up 1.70E03 22 0 down 5.20E03 21 1
Extracellular matrix
cell adhesion 1331 up 1.20E05 166 0 down 2.80E13 137 34
biological adhesion 1344 up 9.00E06 168 0 down 4.30E13 138 35
single organism cell adhesion 684 up 2.00E06 99 0 down 5.40E09 85 18
single organismal cell–cell adhesion 650 up 6.50E06 93 0 down 1.70E09 81 15
homotypic cell–cell adhesion 417 up 6.80E07 69 0 down 1.80E08 63 9
response to extracellular stimulus 800 up 1.30E03 98 0 down 1.20E11 88 14
regulation of cell adhesion 861 up 1.50E03 104 0 down 1.40E10 90 17
leukocyte cell–cell adhesion 400 up 2.40E04 58 0 down 1.90E07 54 7
regulation of cell–cell adhesion 537 up 3.00E03 68 0 down 3.40E07 60 10
cellular response to extracellular
stimulus
313 up 4.00E04 47 0 down 2.80E04 43 8
negative regulation of cell adhesion 309 up 3.10E03 43 0 down 1.30E03 38 7
vasculature
angiogenesis 426 up 7.50E03 54 0 down 6.70E06 50 8
regulation of smooth muscle cell
proliferation
176 up 5.50E04 30 0 down 3.80E03 27 3
protein turnover
regulation of proteolysis 939 up 4.20E03 109 0 down 3.60E12 97 17
post-translational protein modiﬁcation 296 up 4.00E04 45 0 down 4.00E07 42 3
positive regulation of proteolysis 435 up 2.40E04 62 0 down 8.70E07 56 9
regulation of proteolysis involved
in cellular protein catabolic process
340 up 1.40E03 48 0 down 1.40E05 44 6
positive regulation of proteolysis
involved
in cellular protein catabolic process
187 up 7.20E04 31 0 down 8.40E03 28
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regulation of GOs associated with the extracellular matrix matched
the increase in area percentage changes of the extracellular matrix
compartment (compare Table S1 with Fig. 1I and Fig. 5B). In
contrast, changes in the lipidome and lipid area percentage aftertendon release (and repair) were not reﬂected by co-directional
level alterations in transcripts being related to lipid metabolism
(compare Fig. 1H and Fig. 5B). For instance tendon release and
repair elevated the pool size of phospholipids, cholesterols and
fatty acyls consistent with reported alterations of lipid classes in
Fig. 6. Differences in the nandrolone-modulated transcriptome in function of administration. A) Heat map visualizing the regulation of the 10998 affected gene transcripts
which altered their concentration after tendon release in N22W and/or repair in N6W (2% FDR based on SAM). B) Heat map visualizing the p-value weighed regulation of the
128 affected gene ontologies (p-value enrichment < 1% <FDR (Metacore) for altered transcripts (1% FDR based on SAM) which response differed 16 weeks after tendon release
between nandrolone administration (N22W) vs. CONTROL or 6 weeks after repair (N6W) vs. CONROL. Changes of affected gene transcripts (A) and p-values for affected gene
ontologies (B) are given in color-coding (red: up-regulated, blue: down-regulated). Non-signiﬁcant changes are given in grey color.
Fig. 7. Correlation network for alterations in lipid compounds and transcripts. Line
graph displaying the correlations (nodes) between fold alterations in affected lipid
compounds and transcripts (edges), which met the criteria of r > |0.99| for all
studied samples in the three intervention groups. Nodes appear in turquoise and
edges are displayed in grey. Identiﬁed entities are assigned. Entity 1 describes lipid
compounds (654 nodes, 39674 edges), entities 2 (39 nodes, 77 edges) and 3 (14
nodes, 26 edges) describes only gene transcripts.
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composition of adipocytes [42]. However, GOs associated with
lipid biosynthesis were lowered 16 weeks after tendon release (at
repair) and only few transcripts related to adipocyte differentiation
were increased (Fig. 5B). Aside isoform 1 and 2 of the adipocyte
differentiation marker PPARG, this included a 10-fold increase in
negative (adiponectin; ADIPOQ, adipocyte enhancer binding
protein 1; AEBP1) and positive regulators of adipogenesis (adipo-
genesis regulatory factor; ADIRF), the factor of fatty acid uptake
and transport in adipocytes, fatty acid binding protein 4 (FABP4),
and acyl-CoA synthetase medium-chain family member 1
(ACSM1). Other established markers of fat cell differentiation
[43,44] that are increasingly expressed in rotator cuff muscle after
tendon release, such as sterol regulatory element-binding protein
1 (SREBP1) and CCAAT/enhancer binding protein beta (C/EBPb)
[16,18], were not affected at the transcript level (data not shown).
An up-regulation of lipid-associated gene transcripts, including
PPARG, has been observed between 30 days and 16 weeks of
tenotomy [18,41,45]. We corroborate this observation at the
protein level by showing increased PPARG2 protein levels after
16 weeks of tendon release (Fig. 3A–C). Our ﬁndings support
previous results in the rat, showing that fat accumulation with
release of the rotator cuff tendon does not occur by activation of
the canonical intramyocellular lipid storage and synthesis path-
ways [45] but does involve expressional up-regulation of speciﬁc
pro-adipogenic factors.
4.4. Nandrolone and transcript regulation related to lipid biosynthesis
In contrast to the expectation from the lowered abundance of
243 lipid species (Table 2), nandrolone administration up-
regulated transcript level for factors of fat cell differentiation
and lipid biogenesis (Fig. 5B). For instance expression of transcripts
being associated with central aspects of adipocyte differentiation
(PPARG2; [46,47] and the maturation of lipid droplets (perilipin 1;
PLIN1, vimentin, VIM) and FABP4 [48,49] remained unaffected by
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have shown previously that fat cell accumulation in infraspinatus
muscle of sheep continues beyond 16 weeks of tendon release [3].
Collectively this implies that the prevention of fat accumulation in
released infraspinatus muscle is not explained by a block of
adipocyte differentiation, transcriptional down-regulated of lipid
biosynthesis or lipid oxidation. Likely candidate explanations
contributing to the nandrolone-mediated suppression of lipid
biosynthesis, include the post-translational regulation of lipid
biosynthesis in infraspinatus muscle or processes external to the
studied muscle that control the delivery and import of substrates
for lipid synthesis [7,39].
4.5. Nandrolone and androgen receptor expression
Our ﬁndings show that nandrolone administration with tendon
release did up-regulate anabolic receptor protein and total RNA
concentration in infraspinatus muscle of sheep (Fig. 3D/E, Fig. 4).
This observation is consistent with previous ﬁndings on the effect
of anabolic steroid on androgen receptor levels in mice, rat and
humans [28,29,40,50]. Our ﬁndings show that nandrolone up-
regulated transcripts of muscle-associated gene ontologies in line
with a mitigated reduction of the area percentage in muscle ﬁbers
(Fig. 1G). This included prominent factors associated with
contraction such as troponin C and I, myosin regulatory light
chain and actinin, as well as myoglobin. We interpret our ﬁndings
to indicate that the nandrolone-induced increase in androgen
receptor levels are part of a feed forward mechanism that promotes
the genomic effect of androgen signalling on protein metabolism in
muscle ﬁbers.
4.6. Tendon release affects the transcript response to nandrolone
Intriguingly, the absent effect of nandrolone on lipid accumu-
lation when administration started after repair (N6W) was related
to the inversion of the global transcript response compared to the
N22W group when nandrolone was given for the duration of
release (Fig. 6). This result emphasized the reduced responsiveness
of degenerated rotator cuff muscle to stimulation by nandrolone
[30]. As well it was found that androgen receptor levels were not
modiﬁed compared to the CONTROL group in the N6W group
(Fig. 3E). These observations suggest that the reduced responsive-
ness of degenerated rotator cuff muscle to nandrolone is related to
a down-regulation of the genomic response to anabolic steroid. In
this regard it is of interest that androgen receptor density in rat
skeletal muscle is increased by contractile activity and decreased
by steroid treatment [51]. The unaffected androgen receptor levels
in the N6W group imply that this disparity of effect involves
adjustments in the capacity for androgen receptor mediated
signalling in skeletal muscle.
4.7. Relationship between the nandrolone-modulated muscle
metabolome and transcriptome
A considerable portion of the lipid species, of which an
increased pool size after tenotomy was prevented by nandrolone,
are found in plasma membranes, i.e. glycerolipid, phospholipid,
prenol lipid, sphingolipid, sterol lipid. Nandrolone has been shown
before to acutely affect the plasma membrane of many cell types
during its cell entry, i.e. by exerting electrophysiological actions
[52] and inﬂuencing lipid peroxidation [53]. The present novel
observations raise the possibility that the mitigating effect of
nandrolone on lipid accumulation in tenotomised infraspinatus
muscle also involves direct effects on plasma membrane integrity.
Network analysis (Fig. 7) identiﬁes an important number of linear
relationships within the class of lipid compounds, and genetranscripts, including those being associated with the regulation of
lipid metabolism, but not between them. The role of affected
plasma membrane species in respect to the changes in transcript
expression following the early administration of the synthetic lipid
compound, nandrolone, remains to be tested.
4.8. Clinical relevance
Our results provide a number of clinically relevant conclusions.
The nandrolone- and repair-regulated concentration of the
androgen receptor levels and downstream effects on transcript
expression in infraspinatus muscle provides a signpost when the
treatment effects are to be expected. The ﬁndings thereby
emphasize that the speciﬁc importance of muscle activity
regulated androgen receptor expression lies in the modulation
of the effects of nandrolone on muscle fat content [29,51]. As well
we noted that elevated protein expression of PPARG2 after 16
weeks of tendon release resisted to nandrolone administration.
This suggests that differentiation of adipocytes in released rotator
cuff muscle may be irreversibly enhanced within the investigated
time frame. As well we noted an important up-regulation of
transcripts for adhesive processes, which are a prerequisite for
adipocyte differentiation [44,54,55], with tendon release and this
was further enhanced by nandrolone. This evidence for an
enhanced presence of gene messages for pro-adipogenic processes
bears the question for how long the released infraspinatus muscle
is protected from lipid accumulation once nandrolone adminis-
tration is discontinued. Finally, we identify at the level of statistical
signiﬁcance that nandrolone also reduces the loss in muscle ﬁber
area percentage; supporting that nandrolone administration
immediately after tendon release preserves muscle quality by
avoiding the degeneration of contractile material.
5. Conclusion
Our molecular observations imply that the lost responsiveness
of retracted rotator cuff muscle to anabolic steroid in lowering the
pools sizes of lipid compounds is associated with defective,
genomic actions of nandrolone, as reﬂected by a general down-
regulation of transcript expression. Conversely, the prevention of
lipid synthesis in sheep infraspinatus muscle with nandrolone
administration starting immediately after tendon release is
associated with up-regulated androgen receptor protein and
RNA expression. Resistance of the adipocyte marker PPARG to
regulation by nandrolone, indicates that prevention of fat
accumulation in retracting rotator cuff muscle by nandrolone
administration is not mediated by the suppression of adipocyte
differentiation.
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